USD 14.27 billion
Biodefense Market Size, Share, Growth Analysis, By Type(Anthrax, Smallpox, Botulism, Radiation/Nuclear), By Application(Hospitals and clinics, Ambulatory Care Centers, Others), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35H2213 |
Region:
Global |
Published Date: September, 2024
Pages:
157
|Tables:
63
|Figures:
75
Biodefense Market Insights
Biodefense Market size was valued at USD 15.22 billion in 2022 and is poised to grow from USD 15.99 billion in 2023 to USD 23.67 billion by 2031, growing at a CAGR of 5.03% during the forecast period (2024-2031).
The biodefense market growth is driven by the presence of government initiatives, increasing private investment, the increased government spending and focus on biodefense strategies, and cases of the flu, Zika virus, and Ebola virus. Technological advances that have been experienced in genetic engineering and biotechnology within the last two decades make it feasible to modify these naturally occurring, lethal viruses that can readily be redrafted to cause devastation. Moreover, as these organisms are widely present in various parts of the world, biodefense is an integral component for countries across the globe. Some of the prior biological agents that were used as carriers for bioterrorism were anthrax, botulism, and chemical and nuclear agents. This incurred immense monetary loss. As a result of these activities, governments across the globe have enacted biodefense statutes, treaties, and policies aimed at combating biological threats, minimizing risks and preparing for, responding to, and recovering from a manifestation of bioterrorism. In fact, while conducting continuous research to diagnose, treat, and prevent infectious diseases, intentional or naturally occurring, the National Institute of Infectious Disease was able to contribute to the formation of medical products and strategies to fight bioterrorism as well as emerging and re-emerging infectious diseases since the 2001 mail-borne anthrax bioterrorism act.
US Biodefense Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Anthrax
Fastest Growth
Anthrax
Growth Rate
5.1% CAGR
Global Biodefense Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Biodefense Market Segmental Analysis
Global Biodefense Market is segmented by Type, Application, and region. Based on Type, the market is segmented into Anthrax, Smallpox, Botulism, Radiation/Nuclear, Others. Based on Application, the market is segmented into Hospitals and clinics, Ambulatory care centers, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Biodefense Market Analysis by Type
As per the biodefense market analysis, the anthrax segment is led by the industry with a high compound annual growth rate (CAGR) during the forecast period, as per the market share of 28.4% during 2023. Some of the product types included in this market are radiation/nuclear, smallpox, anthrax, and botulism. Anthrax is a product derived from the gram-positive, spore-forming bacterium Bacillus anthracis. It is thought to be one of the most likely agents to be used in a bioterrorist attack. These spores are mainly preferred because they are easily spread in the environment by being added to food, drink, powder, and sprays. They can be readily sourced from natural resources such as soil, plants, or water and have a long shelf-life in the environment.
However, the other segment of the type, in the biodefense market forecast, is expected to grow at a 6.2% CAGR during the projection period. Some of the others include viral hemorrhagic fever, brucellosis, cholera, influenza, plague, food poisoning, tularemia, Zika, Ebola, among a few. The NIAID's VRC, since 2003, has engaged in research into VHF vaccines, particularly a vaccine that would act as a protection mechanism against the Marburg and Ebola viruses. The DoD has also given a contract to the UTSA for developing a tularemia vaccine. High contagiousness and potential lethality characterize tularemia, meaning it may be a bioweapon.
Biodefense Market Analysis by Application
The hospitals & clinics segment comes out as the dominant in the global biodefense industry. These medical setups form mainly the centers of operations for the management and treatment of individuals exposed to biological agents. Thus, they come out quite centrally in biodefense preparedness and response. Hospitals and clinics must be provided with proper biodefense infrastructure that should comprise of the most advanced diagnostic tools, specialized detection and treatment equipment, and biodefense-ready staff to undertake epidemics. These facilities also play a critical role in immunization campaigns, public health campaigns, and emergency response plans. Because of its critical role in preserving public health, it is thus the market leader in the hospitals & clinics segment.
The ambulatory care centers segment is expected to achieve the highest biodefense market share during the forecast period. The growing pressure on decentralized biodefense capabilities and increasing focus on community-based healthcare services have motivated the rapid growth of ambulatory care clinics. Effective response plans rely largely on prompt and easy access to available medical treatment, such as vaccinations, diagnostics, and early identification of biological hazards, which are offered at ambulatory care clinics. This market has grown drastically following the growing need for effective and flexible healthcare delivery strategies, especially in the wake of public health catastrophes.
Global Biodefense Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
Biodefense Market Regional Insights
With a commanding 86.1% biodefense market share in 2023, North America led the industry and is predicted to grow with a strong CAGR throughout the forecast period. Among the many factors constituting this superiority lies huge federal outlays for enhancing public health security and technical advancements that enhance biodefense capabilities. Furthermore, growing public knowledge about biological risks continues to fuel increasing demand for effective response and preparedness plans. Such big giants in the field offer the market a much-required boost by enforcing innovation and newer goods and services upon the earth. All these contribute to reifying North America as the global leader in the biodefense industry.
Asia-Pacific is expected to grow with the highest CAGR of 9.1% during the forecast period due to an increase in R&D expenditure. The market is growing due to the increasing importance of biodefense and the higher risk of deadly biological agents that cause emergencies. Australia and Japan, two of the most advanced biodefense industries of Asia-Pacific, have well-established vaccine production facilities. This, along with the very advanced healthcare system of the country, is playing its impact on its market status. Countries such as China and India are vigorously expanding their R&D capabilities with the intent of facing future biological threats. China is the world's second-biggest spender on research and development after the US. These are the aspects that are supposed to support the biodefense industry in the region.
Global Biodefense Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Biodefense Market Dynamics
Biodefense Market Drivers
Increased Government Investment
- The federal and state government must incur huge expenses towards biodefense programs to strengthen national and public health security. This expenditure is the financing needed to develop vaccines, diagnostics, and treatments so that healthcare systems are ready for any biological threats. Governments have invested in emergency planning infrastructure and training that sketches out a climate under which innovative biodefense solutions can grow. It would eventually lead to building resistance against biological attacks or pandemics.
Rising Threats from Bioterrorism
- The implementation of proper biodefense strategies has become more strongly in demand as pandemics and bioterrorism attacks are rising, with more and more emerging infectious diseases. There is a need for more emerging biodefense technologies as there are more new viruses, and intentional biological attacks are a greater threat. This sense of urgency compels governments and organizations to put more focus on biodefense measures that would protect public health and prepare for future biologic threats. Some investments in such areas involve surveillance systems, the ability to respond rapidly, and integrated healthcare programs.
Restraints
Market Competition
- High competition existing among companies already established in the biodefense market may lead to price wars and low profit margins, which could make it hard for companies looking to enter this market. Large businesses are able to dominate the market because they often possess ample resources and have ongoing relationships with governing bodies. Such firms will often resort to drastic pricing measures in a bid to retain market shares, which may further squeeze profits and limit opportunities for smaller firms to grow and thrive in such an important sector.
Lack of Awareness in Certain Regions
- In many developing countries, a general lack of awareness and preparedness for biological risks could severely curtail the expansion of markets. In numerous regions, a growing demand for robust plans in biodefense may be overwhelmed by public health agendas concerned with more acutely threatening health concerns. This can lead to limited financing and resources for biodefense programs. This lack of infrastructure and knowledge can very well place populations at risk and limit the market's capacity to grow as a whole.
Request Free Customization of this report to help us to meet your business objectives.
Biodefense Market Competitive Landscape
Competition in the biodefense industry is marked by major companies and newly emerging companies' emphasis on innovative solutions. While innovative companies introduce new technologies into the market, established companies exploit large resources and experience. Increases in public-private partnerships are presently working to strengthen research and development endeavors. Such a dynamic environment motivates continuous innovation and a run for appropriate handling of changing biological threats.
Biodefense Market Top Player’s Company Profiles
- XOMA Corporation
- Altimmune Inc.
- Emergent Biosolutions Inc.
- Dynavax Technologies Corporation
- SIGA Technologies
- Elusys Therapeutics Inc.
- Ichor Medical Systems
- Dynport Vaccine Company
- Cleveland Biolabs
- Bavarian Nordic
- Ology Bioservices
- Alnylam Pharmaceuticals Inc.
- BioCryst Pharmaceuticals Inc.
- PharmAthene Inc.
- Profectus Biosciences Inc.
- NanoViricides Inc.
- Takeda Pharmaceutical Company Limited
- Sanofi Pasteur
- GlaxoSmithKline
Biodefense Market Recent Developments
- The US Food and Drug Administration approved the BioThrax vaccine developed by Emergent BioSolutions Inc., (EBS), in March 2024 for the prevention of anthrax illness both before as well as after exposure to it. The company is carrying out active activities that can help it to retain its top status for being the leading supplier of anthrax vaccinations to other organizations.
- The US FDA approved T2 Biosystems Inc.'s T2Biothreat Panel in September 2023. The T2Biothreat identifies six high-priority biothreating diseases in the US. The T2Dx is a molecular diagnostic test for direct-from-blood that can identify and distinguish the six biothreat diseases, including the species responsible for anthrax, from a single sample.
- The US Food and Drug Administration has accepted for review the Biologics License Application for AV7909 or Anthrax Vaccine Adsorbed, Adjuvanted by Emergent BioSolutions Inc. (NYSE: EBS), it notified through a press release issued in June 2022.
Biodefense Key Market Trends
- Modes of Personalized Medicine: One of the major biodefense market trends is the increasing popularity for personalized medicine. It is the molding that gives shape to the development of the customized vaccines and treatments focused on specific groups of people or biological threats. This technology presents many more effective and efficient response mechanisms to infectious illness and emphasizes tailored health solutions. Experts predict that when genomics and biotechnology become advanced, they will be able to create a vaccine. That vaccine will not only be highly effective in fighting off various infections but also specifically tailor-made for the genetic makeup of different populations.
- Emphasis on Community Resilience and Mental Health: Huge steps to resilience building for communities will entail mental health support. Preparation for the community towards predicted biological threats will be highlighted by the public education and mental health services needed. This approach, in doing so, relates to dealing with the psychological impacts of medical disaster and does its best to build stronger, more resilient communities. Consideration of psychosocial concerns beside physical health preparedness will enable such societies to better prepare for and more effectively manage the challenges posed by biological threats.
Biodefense Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the biodefense market outlook can be considered bright, and there is a good prospect for increased growth mainly because of increased government funding, growing awareness of biological risks, and introduction of advanced technology. The readiness and response plans will contain crucial elements of hospitals, clinics, and other ambulatory care facilities. However, challenges such as expensive development costs and stiff regulatory regulations might pose to be some potential bumpy rides to success. Two key factors that will dictate the future course of this market are the emergence of public-private partnerships and a commitment to community resilience. Biodefense capabilities - an attempt to better protect the health of the public from new threats of biological natures, will be required as the world becomes increasingly interconnected.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 15.22 billion |
| Market size value in 2031 | USD 23.67 billion |
| Growth Rate | 5.03% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Biodefense Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Biodefense Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Biodefense Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Biodefense Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Biodefense Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Biodefense Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
